FDA Commissioner Marty Makary called these changes “common-sense reforms” that could expedite the development of cell and ...
2don MSN
Sugar Land OKs $1M incentive to stem cell therapy firm as city develops life sciences ecosystem
Sugar Land has authorized an $1 million incentive for stem cell therapy company Hope Biosciences as city leaders look to ...
"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...
We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...
Pluri (PLUR), an established global leader in the development and manufacturing of cell-based therapeutics, launches new revenue-generating Contract Development and Manufacturing Organization (CDMO) ...
Cellares, the contract drugmaker known for its cell therapy factory-in-a-box, will expand its operations to Europe after ...
The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...
Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...
TOKYO--(BUSINESS WIRE)-- AGC Biologics, your friendly CDMO expert, will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC Inc.’s Yokohama Technical ...
In this free webinar, explore approaches to developing and implementing proliferation, AAV/mRNA potency, cell killing and flow cytometry assays in cell therapy development. Attendees will learn how ...
SUZHOU, China, May 19, 2025 /PRNewswire/ -- Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback